The initial discussions with health care teams regarding treatment options, side effects and long-term expectations are key in navigating a chronic myeloid ...

The evidence for dabrafenib plus trametinib The National Institute for Health and Care Excellence (NICE) recommended the NHS offer dabrafenib plus ...

Receiving a diagnosis of chronic myeloid leukemia (CML) can be overwhelming, but there are questions patients can ask their clinicians to ensure they have ...

The Food and Drug Administration (FDA) has granted traditional approval to Retevmo (selpercatinib) for the treatment of adult and pediatric patients 2 years ...

A medical oncologist provides a comprehensive overview of treatment options for patients with relapsed/refractory chronic lymphocytic leukemia, including ...

I would have never imagined meditation would be part of my recovery after my diagnosis with colon cancer. I must admit, I never practiced this skill until ...

Having a cancer community to lean on was something Annie Bond wished she had when she received a diagnosis of metastatic breast cancer at age 26 in 2015. ...

Video content above is prompted by the following question(s):What is shared decision making and what does the process typically entail?Who is generally ...

Enjoying nature reminded Hughes of hope and renewal, which she noted is important during any cancer treatment. I'm Still MeIt's still me inside — Same hopes ...

Lonely surrounded by the noise.Machines buzzing and beeping.It doesn't stop.Here to take your vitals.Here to take your blood pressure.Here to take your ...

The FDA is set to speed up the review of Tagrisso for patients with EGFR-mutant non-small cell lung cancer. The Food and Drug Administration (FDA) granted a ...

Most cancers diagnosed at an earlier stage have a better prognosis. Detecting and diagnosing cancer earlier can mean there are more treatment options ...